Mandatum Life Insurance Company’s Ares Capital ARCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-24,295
Closed -$534K 82
2025
Q2
$534K Sell
24,295
-7,662
-24% -$163K 0.14% 51
2025
Q1
$708K Buy
31,957
+375
+1% +$8.51K 0.22% 45
2024
Q4
$691K Buy
31,582
+3,581
+13% +$77.3K 0.2% 48
2024
Q3
$586K Buy
28,001
+8,860
+46% +$184K 0.18% 50
2024
Q2
$399K Buy
19,141
+5,967
+45% +$125K 0.13% 52
2024
Q1
$274K Buy
+13,174
New +$267K 0.09% 63

Other funds holding ARCC

Mandatum Life Insurance Company's ARCC Position: Q3 2025 in Review

Mandatum Life Insurance Company sold out of Ares Capital (ARCC) in Q3 2025, closing a stake of 24,295 shares — an estimated $534K sold.

Mandatum Life Insurance Company first reported a position in ARCC in Q1 2024 and held it in 6 quarters. The position peaked at $708K in Q1 2025. 788 funds tracked by Wall St. Rank hold ARCC as of Q3 2025.

  • Mandatum Life Insurance Company reported no remaining Ares Capital position as of Q3 2025 after selling out during the quarter.
  • Mandatum Life Insurance Company sold 24,295 Ares Capital shares in Q3 2025, an estimated $534K.
  • Mandatum Life Insurance Company first reported a position in Ares Capital in Q1 2024 and held it in 6 quarters.
  • Mandatum Life Insurance Company's Ares Capital position peaked at $708K in Q1 2025.
  • 788 funds tracked by Wall St. Rank held Ares Capital as of Q3 2025.

Based on Mandatum Life Insurance Company's 13F filing for Q3 2025, filed 6 Nov 2025.